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 The patient population consisted of a maximum of 18,570 subjects who 
completed the NHANES III questionnaire and examination from 1988 - 1994.  The 
physical examination included such things as body mass index and serum samples, social 
and medical history.  The periodontal examination recorded probing depth, attachment 
loss and gingival bleeding.  Serum samples were analyzed for CRP levels, cholesterol 
levels etc.  Demographic, cardiovascular and oral health variables were compared in 
subjects with a history of heart attack.  Result showed that history of heart attack is 
associated with increased odds ratio for elevated CRP, diabetes, hypertension, 
cholesterol, male gender, non-white race and smoking.  Of the periodontal indicators of 
disease, only gingival bleeding had an increased odds ratio for association with heart 
attack history.  The unadjusted odds ratio was 1.25 with 95% CI[0.84-1.87].  The 
  v 
adjusted odds ratio increase to 1.93 with 95% CI [1.02-3.71].  These findings are 
consistent with previous research indicating that elevated CRP is associated with 
increased risk of heart attack.  The interesting finding of this study is that only gingival 
bleeding, not probing depth or attachment loss, had an increased odds ratio for an 
associated with self-reported history of heart attack.    
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Introduction 
 
Periodontal disease is a chronic, low-grade bacterial infection involving the 
supporting structures of the teeth.  The disease severity is classified according to the 
amount of attachment loss that has occurred.  This loss of bone, connective tissue and 
periodontal ligament (PDL) occurs during an inflammatory reaction, triggered by bacteria 
and mediated by the host.  Recent studies into the acute phase response and its 
involvement in the process of atherosclerosis have shed new light on the possible link 
with periodontal disease.1,2,3,4,5,6  
Löe and Theilade7 showed that inflammation of the gingiva is triggered by 
bacteria, and gingival health returns once the bacteria are removed.  They described the 
qualitative changes in the gingival soft tissues during the progression from gingival 
health to gingivitis.  Page and Schroeder8 reported that periodontal disease has a host 
inflammatory component.  They described the host mediated inflammatory reaction to the 
bacterial trigger.  Types and ratios of host cells defined the initial, early, established and 
advanced lesions.  Histological analysis showed that the host response consisted of 
localized inflammation with infiltration of host immune cells, alteration of soft tissue 
structure, and progressive breakdown of the supporting structures of the teeth.   
Numerous studies have shown that bacteria and bacterial products are capable of 
direct tissue invasion.9,10,11,12  Oral microflora, and the cascade of events that they trigger,  
have both local and systemic ramifications.  Putative periodontal bacteria have been 
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found within arterial plaques.13  Host immune cells specific for oral bacteria have been 
shown to cause widespread systemic complications.  Virulence factors of oral bacteria 
contribute to the pathogenesis of gingivitis and periodontitis.14,15,16 Once these bacteria 
and their products infiltrate the soft tissue, they interact with the host defenses, which 
consists of the cellular and humoral immune response.  
The cellular immune response refers to the localized reactions to foreign material.  
The cells involved in this response are the lymphocytes, natural killer cells and 
phagocytes.  These immune cells recognize the antigen, bind it and facilitate chemical 
breakdown of the antigen.  During this process, parts of the antigen are displayed on the 
outer surface of these cells, which then triggers activation of the humoral immune 
response.  T-cells are responsible for the cell-mediated immunity and are characterized 
by specific surface antigen receptors.  When activated, T-cells proliferate and 
differentiate into memory T-cells and the various types of regulatory and effector T-cells 
such as cytotoxic, helper, and suppressor cells.  Macrophages function in phagocytosis of 
microorganisms, digestion and presentation of antigens to T and B-lymphocytes, and 
secretion of various products, including enzymes, complement components, and 
regulatory molecules (interferon, IL-1).17  Guo et al.,18 studied the T-cell response in 
periodontal disease.  Results showed that CD4+ and CD8+ lymphocytes expressed T1- 
and T2- type cytokine messages.  T1-type cytokine messages are the major activator for 
cytotoxic T-cell differentiation, while the T2-type cytokine message is the major activator 
for Helper T-cells.  This shows that the immune response to periodontal disease triggers 
both cytotoxic and helper T-cells. 
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The humoral immune response involves antibody, complement and other soluble 
molecules.  Chemical messengers, called cytokines, activate this branch of the immune 
system.  Inflamed tissues, which have been compromised by the invading bacteria, also 
release cytokines.  Many cells, including the cells of the cellular immune response, 
produce these cytokines.  B-cells are responsible for the humoral immunity and are the 
precursors of antibody producing B-cells, also known as plasma cells.  B-cells are 
characterized by the presence of surface immunoglobulin.  When stimulated by antigen, a 
process that requires the cooperation of helper T-cells and macrophages, B-cells 
proliferate and differentiate into plasma cells and memory cells.19  Mackler et al.,20 
studied the different subclasses of immunoglobulin (antibody) formed in response to 
putative periodontal pathogens.  
 Activation of the host immune response involves recruitment of immune cells and 
production of protective antibodies.21  Chronic stimulation of the immune response due to 
constant assault by oral bacteria on the periodontium causes release of proinflammatory 
cytokines and other proteins which likely promote soft tissue and bone destruction.21  
Zappa et al.,22 found that there were significantly more fibroblasts, mast cells, 
monocytes/macrophages, and inflammatory cells for progressing periodontitis sites 
compared to the non-progressing sites.  Seymour et al.,23 explained the shift in immune 
cell types within a progressing periodontal lesion.  They described the shift from a 
predominantly T-cell lesion to a B-cell (plasma cell) lesion.  Th1 cells release interleukin 
(IL-2) and interferon-gamma (IFN-gamma), while Th2 cells release IL-4, IL-5, IL-6, and 
IL-10.  Th1 cells tend to activate macrophages, and also respond well to macrophage 
expression of antigen.  Th2 cells tend to increase production of eosinophils and mast 
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cells, and enhance production of antibody, including IgE; these cells respond well to 
antigens presented by B cells.  Once established, each of these responses is able to 
suppress the other through cytokine messengers.  
 The localized immune response and inflammatory reaction caused by the invading 
oral flora during periodontal disease triggers a systemic response from the host.  As we 
stated earlier, oral microflora, and the cascade of events that they trigger, have both local 
and systemic ramifications.  Putative periodontal bacteria have been found within arterial 
plaques.24  Host immune cells specific for oral bacteria have been shown to cause 
widespread systemic complications.  Cytokines (IL-1, TNF, IFG, IL-6, etc) produced and 
released during this immune response are responsible for activating the acute-phase 
response (APR).  Cytokines and their associated inflammatory responses perform 
numerous biologic activities.  Many of these are problematic and therefore suggest they 
have a critical role in causing the destruction of bone and connective tissue in 
periodontitis.  Serum levels and types of T-cell lymphocytes are influenced by the 
presence or absence of periodontal disease.  Takeichi et al.,25 showed that the 
characteristics of the periodontal lesion changed depending on the type of T-cell 
activated.  Fujihashi et al.,26 studied cytokine types found in periodontal lesions.  He 
demonstrated that high levels of IL-6 were produced by gingival mononuclear cells but 
not by peripheral blood mononuclear cells unless cells were stimulated with T cell 
mitogen.  Salvi et al.,27 examined which T-helper cell type predominated in periodontal 
disease.  He concluded that the monocytic (IL-1β and PGE-2) and Th1 (lL-2 and IFN-
gamma) inflammatory mediator levels quantitatively dominate over the Th2 mediators 
(IL-4 and IL-6).  
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   The acute-phase response (APR), unlike the humoral response, is non-specific.17  
Hepatic synthesis of acute-phase proteins (APP) is activated by numerous cytokines.  In 
response to these inflammatory cytokines, acute-phase proteins are produced in great 
quantities.  Some of these APP include the following:  C-reactive protein (CRP), serum 
amyloid A protein, alpha-glycoprotein, ceruloplasmin, alpha-macroglobulins, 
complement components, alpha-antitrypsin, alpha-antichymotrypsin, fibrinogen, 
prothrombin and factor VIII.28  C-reactive protein is clinically the most important APR 
protein because it serves as an indicator of disease and can be easily measured in a 
laboratory.29  The APR mediates inflammation by activating complement.  Complement 
activation allows clearance of antigens, killing of bacteria and regulation of 
inflammation.  CRP activates complement and thus participates in sustaining 
inflammation.17  It was named for its ability to interact with the C-polysaccharide of 
pneumococci and was the first acute phase protein described.  CRP is an active part of the 
acute phase response (APR).  Induction of the APR occurs due to infection, trauma, 
inflammatory processes and some malignant diseases.  Numerous cytokines induce these 
acute phase protein changes, notably IL-1, IL-6 and TNF.17  Biosynthesis of CRP and 
other APP occurs in the liver.30  The APR is responsible for increased production of APP, 
fever and release of ACTH.    The result of the APR is rapid acceleration of the host 
immune reaction.  Normal levels of CRP in the serum are less than 10mcg/l, but it can 
reach levels of >100mg/l within 48 hours of initiation of the APR.  CRP level is not 
influence by anemia or plasma protein changes.  It has a half-life of 5-7 hours and 
reaches peak levels within 48-72 hours.  CRP levels will return to normal levels within 
several days, following resolution of the inflammation or trauma.31  Biosynthesis of these 
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acute phase proteins takes place in the liver and is regulated by a factor known as 
hepatocyte stimulating factor (HSP) – now known as IL-6.19    Fujihashi et al.,26 
demonstrated that high levels of IL-6 were produced by gingival mononuclear cells 
during periodontal disease.  Many now consider quantitative CRP measurements the 
procedure of choice to detect and monitor acute inflammation and acute tissue 
destruction.32   
 Cardiovascular disease is characterized by arteriosclerosis, a generic term for 
three patterns of vascular disease that involve thickening and loss of elasticity of arterial 
walls.  The primary disease is atherosclerosis, which is the formation of intimal fibrous 
plaques that many times have a central lipid core and which protrude into the lumen.  The 
disease begins early in life but symptoms are not evident until later when arterial lesions 
precipitate organ injury.  Myocardial infarction, cerebral infarction and aortic aneurysms 
are the major consequences of this disease.33  Morphology of an atheromatous plaque 
(atheroma) consists of a fibrous cap (proliferating smooth muscle cells, macrophages, 
lymphocytes, foam cells etc), necrotic core (cellular debris, extracellular lipid with 
cholesterol crystals, and foamy macrophages) and neovascularization (proliferation of 
small blood vessels for nutrient supply).  An atheroma is termed complicated once 
changes occur such as calcification, focal rupture or gross ulceration, hemorrhage and 
thrombosis.  Thrombosis of the plaque is the most critical complication due to the 
possibility of partial or complete lumen blockage.  Localized and systemic inflammation 
plays a critical role in the formation and maturation of atheromatous plaques.33 
 Much research has been focused on the association between periodontal disease 
and cardiovascular disease (CVD).  Many risk factors are similar between CVD and 
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periodontal disease.  Grossi et al.,34 discussed several risk factors such as sex, age, 
smoking, diabetes and body mass index.  Beck et al.,35 studied the relationship of 
periodontal disease to carotid artery intima-media wall thickness.  He found that 
compared to healthy subjects, those with moderate periodontitis had an odds ratio of 1.40 
for thickened vessel wall (atherosclerosis), and those with severe periodontitis had an 
odds ratio of 2.09.  Arbes et al.,36 studied the association between extent of periodontal 
attachment loss and self-reported history of heart attack.  The odds ratio for a heart attack 
increased with the severity of periodontal disease, from 1.4 for mild periodontitis up to 
3.8 for severe periodontitis.    Approximately half of all deaths in the U.S. can be 
attributed to complications of atherosclerosis.  Of this number, only half of those deaths 
were associated with high cholesterol.  The medical community needed another marker 
for increased risk of cardiovascular disease.  CRP is a marker for inflammation and can 
accurately predict risk of future cardiac events.32  The AAP parameters of care37 state that 
periodontal pathogens may contribute to atherogenic changes and thromboembolic events 
in the coronary arteries and other arteries.  
CRP functions within the acute phase response.  Its precise role in the 
atherosclerotic event is unclear.  Braunwald et al.,29 states that CRP may activate 
complement and therefore may act to sustain inflammation.  Strandberg et al.,1 studied 
CRP level, cardiovascular risk factors and mortality in the elderly.  After controlling for 
age and sex, baseline CRP level significantly predicted the 10-year total mortality and 
cardiovascular mortality.  Ridker et al.,2 studied CRP and the risk of future cardiovascular 
events among healthy women.  He found the higher the level of CRP, the higher the risk 
of CVD (5 fold increase) and MI or stroke (7 fold increase).  Rifai et al.,3 looked at novel 
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risk factors for systemic atherosclerosis.  He found that baseline plasma levels of 
Tc:HDL-c ratio and CRP were the strongest independent predictors of development of 
peripheral arterial disease.  Noack et al.,4 reported the range for CRP as a risk factor for 
CVD, peripheral vascular disease, or stroke is 1.34mg/dL to 6.45mg/dL and the mean of 
this range is 3mg/dL.  These studies show that CRP is a reliable marker for 
cardiovascular disease risk and the risk of CVD increases as the level of CRP increases. 
Elevation in systemic CRP levels can be seen in subjects with periodontal 
disease.4,5,6  As the severity of periodontal disease increases, so does the level of CRP.  
Noack et al.,4 studied the contribution of periodontal infection to elevated systemic CRP 
level.  Subjects with periodontal disease had higher levels of CRP vs. healthy controls.  
Subjects with high clinical attachment loss had higher mean CRP levels vs. healthy 
controls.  The presence of periodontal pathogens in samples was positively associated 
with elevated CRP levels.  Loos et al.,5  studied the elevation of systemic markers related 
to cardiovascular disease in the peripheral blood of periodontitis patients.  He found that 
both generalized periodontitis and localized periodontitis subjects had elevated CRP vs. 
controls.  52% of generalized and 36% of localized periodontitis subjects were 
seropositive for IL-6 (a potent activator of CRP) vs 26% of controls.  Ebersole et al.,6 
studied the systemic acute-phase reactants, CRP and haptoglobin, in adult periodontitis 
subjects.  The mean CRP levels in adult periodontitis subjects were 9.12mg/dL vs 
2.17mg/dL for healthy controls.  An interesting finding of this study was that 
administration of an anti-inflammatory drug (flurbiprofen) decreased the level of CRP by 
35-40%.  
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In order to study the association between periodontal disease and CRP we must 
first understand the limitations of classifying a site in the mouth as either being active or 
inactive.  Periodontal disease has been characterized as a disease in which there are 
exacerbations and remissions.38  Periodontal disease is classified according to the amount 
of attachment loss present, not evidence of current disease.  Clinical findings for 
indicators of periodontal disease must be considered collectively in order to label a site as 
active or inactive.  Clinical findings include the following: color (redness), swelling, 
bleeding on probing, probing depth and clinical attachment level. 
 Redness is associated with increased vascularity, capillaries and blood cell 
infiltrate.  Löe and Theilade7 included redness as a component of the gingival index.  
Redness was said to be a visual clue to the histologic change caused by the inflammatory 
process.  It can be used to assess the severity of gingival inflammation.  The presence of 
redness indicates tissues are no longer healthy.  Redness alone is not a good predictor of 
disease progression.  The absence of redness is an excellent negative predictor of disease 
progression. 
 Suppuration refers to purulent exudates or pus associated with the sulcus of a 
tooth.  The world workshop(WWS), Annals of Periodontics,39 defined suppuration as a 
neutrophil-rich variant of gingival crevicular fluid (GCF).  Suppuration is said to be an 
uncommon finding with gingivitis alone.  As periodontitis severity increases, suppuration 
accumulates in the pocket.  In this review of literature, suppuration was found in only 3-
5% of sites with periodontitis, but its presence had a strong association with progression 
of disease.  Absence of suppuration had a high negative predictor value for progression of 
periodontitis. 
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 Bleeding on probing (BOP) can be used to assess the extent of gingival 
inflammation.39  Assessing BOP is complicated by factors such as the method of probing, 
time factor to observed bleeding and the qualitative assessment of bleeding.  A meta-
analysis from the Annals of periodontics39 found that BOP was a reliable sign of 
inflammation and BOP is an important risk predictor for increased loss of attachment.  In 
the analysis, the odds ratio of increased loss of attachment for patients with frequent BOP 
during maintenance period was 2.79.  Davenport et al.,40 studied histometric comparison 
of active and inactive lesions in advanced periodontitis.  The study consisted of 
examining bleeding/suppurating and nonbleeding/nonsuppurating periodontitis lesions.  
The percent of infiltrated CT and the number of plasma cells and leukocytes were higher 
in bleeding than in nonbleeding sites.  Bleeding and/or suppuration were indicative of 
histopathologic changes in lesions of advanced inflammatory periodontal disease but PD 
and AL were similar for all lesions.  Caton et al.,41 studied the association between 
bleeding and visual signs of interdental gingival inflammation.  Bleeding was found in 
39% of visually non-inflamed areas.  This indicates that bleeding indices were more 
sensitive to inflammation than visual verification.  Greensteen et al.,42 reviewed the 
literature to study the role of BOP in the diagnosis of periodontal disease.  The authors 
state that bleeding reflected the histological (or inflammatory changes), clinical and 
bacteriological (spirochetes and motile rods) alterations associated with periodontal 
disease.  The authors found that BOP was better than visual signs of inflammation (color 
changes) as an earlier sign of gingivitis.  Muhlemann et al.,43 concluded that bleeding 
from the sulcus is the earliest clinical symptom of gingivitis and that it precedes 
discoloration and swelling of gingival units.  Bleeding from the gently probed sulcus 
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precedes the appearance of gingival color changes and is the leading and first clinical 
symptom of marginal gingivitis.  In a study of nearly 5000 subjects who were questioned 
about their oral health, and cardiovascular disease, Buhlin et al.,44 found that bleeding 
was the only significant factor for increased odds ratio for self reported heart attack. 
 Probing depth is defined by the 1996 World Workshop of Periodontics45 as the 
distance from the gingival margin to the base of the probable crevice.  The periodontal 
pocket is important because it is the major habitat for putative periodontal pathogens and 
the route of invasion of bacteria and bacterial products.  Kepic et al.,46 showed that if the 
pocket can be cleaned such that all the plaque and most of the calculus is removed, 
gingival health could be returned.  Increasing depths of the periodontal pocket complicate 
cleaning efforts.  Caffessee et al.,47 showed the difficulty in adequately cleaning deep 
pockets (>5mm).  Long term maintenance studies have shown that in general, patients 
can maintain gingival health if their probing depths are not greater than 3mm.  This is not 
to say that all pockets deeper than 3mm are “active” and will progress with continued 
attachment loss.  Only a small percentage of longitudinally monitored sites with deep 
probing depths are at an increased risk for progression.  The significance of probing 
depth must be considered.  Goodson et al.,48 showed that when left untreated, only 5.7% 
of deep probing depths (≥4mm) lost attachment over 13 months.  Lindhe et al.,49  found 
that deep probing depths (> or = 5mm) have low positive predictive value for future 
disease progression, but have a high negative predictive value for disease progression.  
When probing depths are monitored over time and can be compared, increasing probing 
depth has predictive value.  Badersten et al.,50 found that probing depth increases of  ≥ 
1mm was 80% predictive of future attachment loss.  Claffey et al.,51 found the 
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combination of increased probing depth and BOP had the highest predictive value(87%), 
for future loss of attachment.      
 The aim of this study is to use the NHANES III database to collectively compare 
the indicators of periodontal disease to known cardiovascular risk factors in patients with 
a history of heart attack. 
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Materials and Methods 
 
The National Health and Nutrition Examination Survey (NHANES) III involved 
data collection from 1988 through 1994.  Approximately 40,000 subjects, 2 months of 
age and older, were randomly selected from households across the U.S. to participate.  
Participants were asked to volunteer for interviews, extensive physical and dental 
examinations and biochemical tests.  All tests were performed in the mobile examination 
center (MEC).  
Serum Collection.  During the MEC examination, a 6-cm3 specimen of venous 
blood was collected in a vacutainer tube containing a Ficoll heavy-density layer overlaid 
with a thixotropic gel followed by ACD anticoagulant from examinees 12 years of age 
and over.  The serum will be analyzed for CRP levels using non-hs-CRP ELISA.   
Periodontal Examination.  The NHANES III periodontal examination was 
performed on subject 13 years old or older.  Only fully erupted permanent teeth were 
measured.  The exam used the NIDR probe which was yellow color-coded and graduated 
at 2,4,6,8,10 and 12 millimeters.  The NIDR probe point diameter was 0.38 millimeters.  
The instructions given to the examiners were the following: Probe is to be held with a 
light grasp not to exceed 25 grams and pointed toward the apex of the tooth.  Each 
measurement is rounded to the lowest whole millimeter.  The probe is inserted from the 
buccal aspect to measure both buccal and mesial sites.  For the interproximal site the 
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examiner should keep the probe parallel to the long axis of the tooth even if the adjacent 
tooth is missing.  For upper and lower molars the buccal assessment are made at the 
midpoint of the mesial root, keeping the probe parallel to the long axis of the tooth. 
 Gingival Assessment.  The NHANES III gingival assessment instructions to the 
examiners was as follows: The buccal and mesiobuccal sites of each tooth are to be 
assessed.  Score of 0=No bleeding, 1=bleeding, Y=cannot be assessed.  Buccal aspects of 
each quadrant are to be carefully dried prior to gingival assessment.  Begin assessment 
for the most posterior tooth.  Placement of the probe: NIDR probe inserted no more than 
2 mm into the sulcus, starting just distal to the midpoint of the buccal surface and then 
moved gently into the mesial interproximal area.  After all sites from the facial or buccal 
aspect of a single quadrant are examined in this fashion, the bleeding points are scored. 
 Periodontal Destruction Assessment.  The NHANES III periodontal destruction 
assessment included both an assessment of loss of attachment and furcation involvement. 
For loss of attachment, the exam will look at two sites per tooth, buccal and mesiobuccal.  
Loss of Attachment was defined as the distance in millimeters (mm) from the 
cementoenamel junction (CEJ) to the bottom of the pocket.  At each site measured, first 
the distance from the free gingival margin (FGM) to the CEJ, and second the distance 
from the FGM to the bottom of the pocket will be measured.  Where the gingival margin 
is subject to recession and the CEJ is exposed, the distance from the CEJ to the gingival 
margin is called a negative value.  Measurements range from 0 to 12 millimeters.    
 Statistical analysis: Statistical analysis was performed using SPSS software.  A 
bivariate analysis was performed for all variables to determine independent significance.  
A logistic regression model adjusted for age, gender, race, CRP level, diabetes, 
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hypertension, cholesterol, marital status, education, gingival bleeding and smoking was 
then performed for those significant variables.  
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Results 
 
Description of subjects: 
Table 1 shows that a total of 18,570 patients filled out a questionnaire, which 
asked the following demographic information: Age, Gender, Race/ethnicity, Income, 
Marital status and Education.  
 
Variable N % 
Age (years) 18570 100 
20-39 7264 39.1 
40-49 2757 14.8 
50-59 2024 10.9 
60-69 2574 13.9 
>69 3951 21.3 
Gender 18570 100 
Male 8705 46.9 
Female 9865 53.1 
Race/ethnicity 18570 100 
Non-hispanic white 8096 43.6 
Non-hispanic black 5013 27.0 
Hispanic 4754 25.6 
Other 707 3.8 
Income (dollars) 18142 100 
<$20,000 8993 49.6 
>$20,000 9149 50.4 
Marital status 18497 100 
Married 11081 60.0 
Widowed 2326 12.6 
Divorced 2046 11.0 
Never married 3026 16.4 
Education 18371 100 
8 years 4586 25.0 
9-11 years 3057 16.6 
12 years 5525 30.1 
>12 years 5203 28.3 
Table 1. Demographic Characteristics of study population 
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 The age of the subject population was divided into 5 groups.  The largest 
percentage of subjects was in the 20-39 year old group (39.1%).  The mean age of 
subjects with a negative history of heart attack was 48.46 years old.  The mean age of 
subjects with a positive history of heart attack was 69.65 years old.  The gender of the 
population was divided all but equally between males and females.  Males accounted for 
46.9%, and females accounted for 53.1% of the subjects.  Race was divided into 4 
groups.  Non-hispanic whites accounted for 43.6%, Non-hispanic blacks accounted for 
27.0%, Hispanic subjects accounted for 25.6% and the last group, Other, accounted for 
3.8%.  Income status of the subjects was broken into two groups, >$20,000 (49.6%) and 
<$20,000 (50.4%).  Marital status was divided into four groups.  Married subjects were 
the largest group with 60.0% of the total.  Those subjects never married were 16.4% of 
the population.  Widowed and Divorced groups were similar at about 12% each.  The 
amount of education of the subjects was divided into four groups.  The first group is 
subjects who had 8 years of education (25.0%).  The second group consists subjects who 
have had 9-11 years of education (16.6%).  The third group consists subjects who have 
had 12 years of education (30.1%).  The final group consisted of subjects with >12 years 
of education (28.3%). 
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 Table 2 shows several cardiovascular risk factors for the study population.   The 
percentage of subjects with either Type I or Type II diabetes was 8.5%.  This is consistent 
with the national prevalence of 8.2%.  The NHANES III categorized a patient as 
hypertensive if a participant reported any of the following:  patient was told that she or he 
had high BP, current use of medications to treat high BP, or if the average measured BP 
was ≥140 mmHg systolic, or ≥90 mmHg diastolic.  28.9% of subjects were classified as 
hypertensive.  The cutoff value for high or low cholesterol was 200mg/dL.  60.7% of the 
subjects had normal cholesterol, while 39.3% have high cholesterol.  Subjects who 
currently smoke accounted for 50.1% of the subject population.  Body mass index (BMI) 
Variable N % 
Diabetes 18548 100 
Yes 1580 8.5 
No 16968 91.5 
Hypertension (>140,>90) 18398 100 
Yes 5321 28.9 
No 13077 71.1 
Cholesterol (mg/dL) 14750 100 
<200 8952 60.7 
>200 5798 39.3 
Smoking 9570 100 
Yes 4799 50.1 
No 4753 49.9 
Body mass index 14834 100 
<25 4780 32.2 
25-29 3718 25.1 
>29 6336 42.7 
C-reactive protein (mg/dl) 18570 100 
<2.1 4730 30.4 
2.1-5.0 11469 61.8 
>5.0 2371 8.2 
Table 2. Cardiovascular risk factors for study population 
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was calculated as weight in kilograms/height in meters squared, or weight (lbs) ÷ height 
(in) ÷ height (in) × 703.  BMI was divided into 3 groups: Health weight (<25), 
Overweight (25-29) or Obese (>29).  Healthy BMI subjects accounted for 32.2% of the 
subject population.  Overweight subjects accounted for 25.1% of the population.  The 
largest BMI group was the obese group, which accounted for 42.7% of the population.  
C-reactive protein data is divided into 3 groups.  At the time when the NHANES III CRP 
level analysis was performed, high-sensitivity CRP analysis was not available.  CRP 
levels less than 2.1mg/dL were not quantifiable.  With this less sensitive method, the 
NHANES III defined the lowest level of CRP as <2.1mg/dL.  The second level of CRP is 
2.1-5.0mg/dL.  The highest level of CRP is >5.0mg/dL.  This study used data from the 
NHANES III, which shows that 30.4% of the subjects had CRP levels less than 
2.1mg/dL.  The second CRP group in the NHANES III (2.1-5.0mg/dL) accounted for 
61.8% of the subjects.  The last CRP group (>5.0mg/dL) accounted for 8.2% of the 
subjects.  The CRP data shows that approximately 70% of the subjects had moderate to 
severe elevation in CRP levels. 
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Oral health data can be seen in Table 3.  Of the 17,809 subjects responding to the 
history of a dental exam question, 97.1% said they had undergone a dental exam in the 
past.  The dentate status of the subjects was also included.  92.8% of subjects reported 
they had teeth present.  Mean attachment loss data was divided into two groups, greater 
than or less than 4 mm.  82.6% of subjects had <4mm of mean attachment loss, and 
17.4% had attachment loss greater than 4 mm.    Mean Probing depth is given as either <3 
mm or >3mm.  31.6% of the subjects had a mean probing depth >3mm.  This finding 
corresponds with the work of Oliver and Brown (1998), which showed that 
approximately 30% of the population, has periodontitis.  Subjects were divided into three 
groups based upon bleeding on probing(BOP).  29.5% of the subjects had <20% of sites 
with BOP.  5.4% of the subjects had between 20 and 40% of sites with BOP.  The 
Variable N % 
Dental examination 17809 100 
Yes 16593 97.1 
No 496 2.9 
Dentate status 15847 100 
Edentulous 1176 7.2 
Teeth present 14671 92.8 
Mean attachment loss 8901 100 
<4mm 7352 82.6 
>4mm 1549 17.4 
Mean probing depth 8901 100 
<3mm 6090 68.4 
>3mm 2811 31.6 
Gingival bleeding (% sites) 9954 100 
<20% 2932 29.5 
21-40% 541 5.4 
>40% 6481 65.1 
Table 3. Oral health variables of study population 
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greatest number of subjects (65%) had greater than 40% of sites with BOP.  The BOP 
results of this study are consistent with previous studies for a randomly selected 
population.52 
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Variable % with history of 
Heart attack 
Odds Ratio 95%CI 
C-reactive protein (mg/dL)    
<2.1 6.8   
2.1-5.0 76.8 2.81 [1.84,4.71] 
>5.0 16.4 2.64 [1.59,5.11] 
Diabetes    
No 77.6   
Yes 22.4 1.89 [1.29,2.77] 
Hypertension (>140,>90)    
No 57.7   
Yes 42.3 1.82 [1.33,2.50] 
Cholesterol (>,< 200 mg/dL)    
<200 54.0   
>200 46.0 1.69 [1.25,2.32] 
Age (years)    
20-39 2.5   
40-49 14.8 12.08 [1.57,93.23] 
50-59 10.8 22.68 [3.05,168.86] 
60-69 23.8 39.82 [5.46,290.64] 
>70 57.6 68.67 [9.41,501.27] 
Gender    
Female 39.6   
Male 60.4 2.2 [1.53,3.18] 
Race/ethnicity    
Non-hispanic white 63.4   
Non-hispanic black 19.5 1.75 [1.07,2.78] 
Hispanic 14.6 1.82 [1.08,3.03] 
Other 2.5 1.69 [0.57,6.25] 
Marital status    
Married 61.2   
Widowed 25.9 2.07 [0.61,7.05] 
Divorced 9.4 2.04 [0.57,7.26] 
Never married 3.4 2.78 [0.76,10.14] 
Education    
>12 years 19.7   
<9 years 37.2 1.28 [0.77,2.12] 
9-11 years 19.6 1.69 [1.01,2.82] 
12 years 23.5 1.53 [0.98,2.37] 
Gingival Bleeding (% sites)    
<20% 29.0   
20-40% 6.7 1.95 [1.02,3.71] 
>40% 64.3 1.23 [0.86,1.74] 
Smoking    
No 49.9   
Yes 50.1 2.93 [2.14,3.15] 
Table 4. Adjusted odds ratios for study population with positive history of heart attack 
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 Table 4 shows the results of the multiple regression model using the listed 
variables.  All subjects on this table had a positive history of heart attack.  The first group 
in each category is considered the control for comparison by the other groups.  The 
number of subjects with a positive history of heart attack was 937, approximately 5% of 
the total subjects.  The number of subjects with a negative history of heart attack was 
17,633.  The mean CRP level of subjects with a positive history of heart attack was 3.12 
mg/dL.  The mean CRP level of subjects with a negative history of heart attack was 4.42 
mg/dL.  The listed odds ratio values refer to the odds of those subjects with positive 
history of heart attack also falling into the specific category of the variable in question.  
The odds ratio for Subjects with a positive history of heart attack to also have a CRP 
level of 2.1-5.0 mg/dL is 2.81 compared to those subjects with CRP levels <2.1 mg/dL.  
The odds ratio for subjects to fall into the highest group of CRP was 2.64.  This data is 
consistent with previous research showing a trend for increased odds ratio for higher CRP 
levels in subjects with a history of heart attack.  Subjects with positive history of heart 
attack had a 1.89 odds ratio for diabetes.  This increase risk for diabetes to be found in 
subjects with a history of heart attack is consistent with previous research.  Patients with 
a history of heart attack also had an odds ratio of 1.82 for hypertension (>140 systolic, 
>90 diastolic).  The odds of subjects having high cholesterol (>200) was 1.69.  The 
category of age has the highest odds ratios for any parameter studied.  Subjects with a 
history of heart attack have a much higher odds of being in the older age groups.  
Subjects between the ages of 40-49 have an odds ratio of 12.08.  This increases to 68.67 
for those subjects >70 years old.  There is an adjusted odds ratio of 2.2 for subjects to be 
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male.  When the data is adjusted, heart attack subjects have an increased odds (1.69-1.82) 
of being non-white.  Those subjects who were never married have an adjusted odds ratio 
of 2.78, higher than that of both widowed and divorced subjects.  When the data is 
adjusted, education no longer has a clear correlation with odds of heart attack.  The odds 
ratio for heart attack subjects to be smokers was 2.93.  Of the oral health parameters, only 
gingival bleeding resulted in an unadjusted increased odds ratio (1.25 with a 95%CI of 
[0.84,1.87]).  When adjusted for other study variables, the odds ratio increased to 1.93 
with a 95% CI [1.02,3.71].  Probing depth and attachment loss were not included because 
they were not found to be significant.   
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Discussion 
 
 The association between periodontal disease and cardiovascular disease has been 
the topic of numerous studies.  The direct link has yet to be found.  The results of this 
study supports the hypothesis that periodontal disease may directly and/or indirectly 
facilitate atherosclerotic events. 
 Numerous studies of late have shown an association between increased severity of 
periodontal disease and increased risk of cardiovascular disease (CVD).5,36,44,54  This 
study found the adjusted odds ratio for heart attack when compared to attachment loss 
(AL) was not significant.  This contradiction in findings may be due to the disease status 
of the subjects.  At a mean of >4mm attachment loss, the subjects in this study may not 
have had active disease.  The problem when analyzing AL is than the value does not 
allow differentiation between current and past disease.  Attachment loss was recorded as 
a mean value, < or > than 4 mm.  The AAP defines periodontal disease according to 
attachment loss.  Attachment loss of 1-2mm is classified as mild periodontitis, if the 
attachment loss is 3-4 mm the disease is classified as moderate periodontitis, and a loss of 
5mm or more is classified as severe periodontitis.  Noack et al.,4 examined CRP and 
periodontal disease.   In that study, attachment loss was divided into 3 groups.  The first 
group was a control groups with ≤2 mm of attachment loss.  The second groups was the 
mild group with >2 mm and ≤3 mm of attachment loss.  The final group was the severe 
group with >3 mm of attachment loss.  Noack also used high-sensetivity test for CRP.  
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Noack found that subjects with high levels of attachment loss had significantly higher 
CRP levels (4.06 mg/dL vs. 1.70 mg/dL for controls).  Due to the attachment loss 
classification discrepancy, it is difficult to compare the current study with the Noack 
study.  Previous studies have also shown a possible association between periodontal 
disease and atherosclerosis, myocardial infarct and stroke.13,35,53   Arbes et al.,36 found the 
odds ratio for heart attack increased with the severity of periodontal disease.  After 
adjusting for age, sex, race, poverty, smoking, diabetes, high blood pressure, body mass 
index and serum cholesterol, subjects classified as mild periodontitis (≤ 33% sites with ≥ 
3mm attachment loss) had an OR of 1.4.  Moderate periodontitis subjects (33-67% of 
sites with attachment loss ≥3mm) had an OR of 2.3.  Severe periodontitis subjects (>67% 
of sites with attachment loss ≥ 3mm) had an OR of 3.8.  In a study of subjects with a 
recent history of acute cardiovascular disease, Mattila et al.,13 showed that patients with 
recent CVD had significantly more dental infections than healthy controls. 
 Past research comparing periodontal disease and CRP have shown that as the 
severity of periodontal disease increases so does the level of CRP.4,5,6,54  Wu et al.,54 
found a significant relationship between indicators of poor periodontal health (bleeding, 
PD, AL) and increased CRP.  The current study divided subjects into three groups based 
on the level of CRP.  The lowest group included subjects with <2.1 mg/dL.  The second 
group consisted of subjects in the range of 2.1-5.0 mg/dL.  And the final group were 
those subjects with >5.0 mg/dL.  A comparison of this study with others reveals a flaw in 
CRP level categories.  As stated earlier, the NHANES III did not use hs-CRP to 
determine the level of CRP in the serum.  2.1 mg/dL was the lowest level of detectable 
serum CRP.  This value is much higher than that shown to be within a healthy range.  
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Current literature supports that a CRP level of 2.1mg/dL is not healthy and is in the 
medium-risk category for cardiovascular events.2  Loos et al.,5 found that healthy controls 
had a median CRP value of 0.90 mg/dL, while generalized periodontitis subjects had a 
CRP level of 1.45 mg/dL.  Noack et al.,4 reported the range for CRP as a risk factor for 
CVD, peripheral vascular disease, or stroke is 1.34 mg/dL to 6.45 mg/dL with a mean of 
3 mg/dL.  Slade et al.,55and Koenig et al.,56 found that CRP level of 3.0 mg/dL is the 
mean value correlated with high risk for cardiovascular events.  In the present study, the 
mean CRP level of subjects with a positive history of heart attack was 3.12 mg/dL.  
Ebersole et al.,6 found that patients with chronic periodontitis had a mean CRP level of 
9.12mg/dL compared to healthy controls who had a mean CRP level 2.17 mg/dL.   
 CRP is involved with the acute phase response which is associated with 
inflammation and infection.  An increase in CRP occurs with bacterial infections, 
inflammatory conditions (acute rheumatic fever, acute rheumatoid arthritis), myocardial 
infarction, transplant rejection, embolus, inflammatory bowel disease, during the last half 
of pregnancy, with oral contraceptives, and with some malignancies.17  Due to the fact 
that periodontal disease is a chronic low-grade bacterial infection, activation of the acute 
phase response and subsequent increase in CRP appears likely.  The exact cause and 
effect relationship is hard to verify due to the numerous separate factors which also cause 
an increase in CRP.  Ridker et al.,57 examined the role of stain therapy on CRP levels.  
Subjects with low lipid levels and high CRP were able to decrease their CRP level 14.8% 
by taking a statin drug alone (lovastatin).  Ebersole et al.,6 administered a statin drug 
(flurbiprofen) to patients with chronic periodontitis and was able to lower CRP levels by 
35-40% without any other therapy.  The body mass index of the subject will also affect 
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the level of CRP.  The likely association with adipose and CRP levels involves cytokines.  
Human adipose tissue expresses and releases IL-6, a potent proinflammatory cytokine.58  
Visser et al.,59 found that increased BMI value resulted in increased CRP levels.  In that 
study, subjects classified as both overweight and obese were found to have increased 
levels of CRP.  These authors state that the health of both overweight and obese subjects 
is similar to a person that has a low grade systemic inflammation.  In the present study, 
when compared to BMI value, there was no significant increase in odds ratio for a heart 
attack.  
 Systemic health variables had odds ratios consistent with previous studies.  Heart 
attack positive subjects were associated with increased odds ratio of elevated CRP levels 
2.81(2.1-5.0 mg/dL) and 2.64 (>5.0 mg/dL).  There was an increased odds ratio (1.89) for 
diabetes in subjects with history of heart attack.  This is consistent with known risk.  The 
American Heart Association60 estimates that the prevalence of hypertension in diabetics 
is 1.5 – 3 times higher than nondiabetics and between 40-60% of subjects with diabetes 
have high blood pressure.  Heart attack positive subjects in this study had an adjusted 
odds ratio for hypertension of 1.69.  The fact that hypertension is associated with risk of 
heart attack is not surprising.  Blood pressure is believed to be a critical factor for 
cardiovascular health.  Increased blood pressure increases the risk of cardiovascular 
disease.61  In a meta-analysis of over 400,000 subjects, a 7–mm Hg increase in diastolic 
blood pressure over any baseline reading was associated with a 27 percent increase in 
CHD risk and a 42 percent increase in stroke risk.62  In this study, subjects with a positive 
history of heart attack had and odds ratio of 1.69 to also have high cholesterol level 
(above 200 mg/dL).  Periodontal disease has been linked to higher levels of cholesterol.   
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Losche et al.,63 found there was significantly higher levels of total cholesterol, LDL, 
triglycerides and blood glucose in periodontally diseased subjects.  Numerous 
retrospective and cross-sectional studies suggest the association between increased LDL 
and vascular risk.29  Medical treatment of high cholesterol generally focuses on diet, 
exercise and statin drugs such as atorvastatin (Lipitor).  These statins are competitive 
inhibitors of HMG-CoA reductase, a rate-limiting enzyme of cholesterol synthesis.   
Ridker et al.,64 found the combination of TC:HDLC had a relative risk of future 
myocardial infarction to be 3.0, among apparently healthy middle aged men.  Statins have 
been shown to decrease risk of coronary events in patients with high lipid levels 
regardless of the CRP levels, due to their effect on lipid profiles.57  Age had the highest 
odds ratio for association with positive history of heart attack.  Subjects >70 years old 
had an odds ratio of 68.67.  Male subjects had an adjusted odds ratio of 2.2 for an 
association with positive history of heart attack.   There was an adjusted odds ratio of 
1.69-1.75 for heart attack subjects to be non-white.  Increased odds ratio for heart attack 
subjects to be non-married (O.R. 2.04 - 2.78).  The 95% confidence interval (<1) of the 
marriage data brings into question the actual significance of this variable.  After adjusting 
for confounding variables, the education level of the subjects was not significant at 95% 
CI.  Those subject who smoked (50.1% of the sample population) had an adjusted odds 
ratio for an association with positive history of heart attack of 2.93.  The center for 
disease control (CDC) reported 26.4% of adult men and 22.0% of adult women in the 
United States are smokers, representing 47.2 million lives.65  There is a 
disproportionately high number of smokers (50.1%) in the present study.  This may result 
in higher odds ratio for an association with heart attack.  Regardless, smoking is a 
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significant risk factor for heart disease, and the subjects with positive history of heart 
attack had a higher odds ratio association with smoking.  The CDC also reported that 
smoking had a relative risk of 2.5 for coronary heart disease. Overall, smokers have a 
70% greater level of CVD risk than nonsmokers and persons who smoke at least 2 packs 
of cigarettes per day have a two- to threefold greater risk for CVD.65  
 The Interesting finding of this study involves the association between gingival 
bleeding and heart attack.  Bleeding was the only significant oral health factor associated 
with increased risk of heart attack.  Neither probing depth, nor attachment loss was found 
to be significant.  The adjusted odds ratio for heart attack positive subjects to be within 
the 20-40% BOP group was 1.95.  The adjusted odds ratio for subjects with >40% of 
sites with bleeding was 1.23.  As discussed earlier, bleeding is a sign of inflammation and 
when it is used collectively with other clinical findings, bleeding can be a predictor of 
future disease progression.  The results of this study agree with that of Buhlin et al.44 In 
that study, bleeding was the only significant factor for increased odds ratio for self 
reported heart attack.  Buhlin used questionnaires of 2,839 randomly selected Swedish 
subjects.  The questionnaire asked knowledge about dental care habits, oral health, 
cardiovascular disease and socioeconomic variables of income, education etc.  Buhlin 
found there was a significant association between self-reported bleeding gums (odds ratio 
1.60) and known cardiovascular disease.  This current study also agrees with the finding 
of Morrison et al.66  In that retrospective cohort study, using data from the 1970-1972 
Nutrition Canada Survey (NCS), Morrison found that subjects with mild or severe 
gingivitis had a higher relative risk (RR 2.15, 95%CI) of dying of coronary heart disease 
than those subjects with periodontitis.  Bleeding may be more accurate than the 
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measurement of attachment loss or probing depths when assessing active periodontal 
disease.  This study supports the association of oral health findings as markers for risk of 
cardiovascular disease.   
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